Indications for use of Hydrea: – resistant chronic myeloid leukemia; – locally advanced squamous cell carcinoma of the head and neck (excluding the lips) in combination with chemoradiation therapy. –
Mylotarg Treatment of newly diagnosed CD33-positive acute myeloid leukemia in adults and children over 1 month of age. Treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and